Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2018, Article ID 6727421, 12 pages
https://doi.org/10.1155/2018/6727421
Review Article

Peroxisome Proliferator-Activated Receptor γ and PGC-1α in Cancer: Dual Actions as Tumor Promoter and Suppressor

Department of Biochemistry, Dong-A University College of Medicine, Busan, Republic of Korea

Correspondence should be addressed to Joo-In Park; rk.ca.uad@krapij

Received 7 September 2017; Revised 16 December 2017; Accepted 19 December 2017; Published 21 January 2018

Academic Editor: Annamaria Cimini

Copyright © 2018 Seong-Hoon Yun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Mangelsdorf, C. Thummel, M. Beato et al., “The nuclear receptor super-family: the second decade,” Cell, vol. 83, no. 6, pp. 835–839, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Schoonjans, B. Staels, and J. Auwerx, “The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation,” Biochimica et Biophysica Acta—Lipids and Lipid Metabolism, vol. 1302, no. 2, pp. 93–109, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. T. M. Willson, P. J. Brown, D. D. Sternbach, and B. R. Henke, “The PPARs: from orphan receptors to drug discovery,” Journal of Medicinal Chemistry, vol. 43, no. 4, pp. 527–550, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Tontonoz, E. Hu, R. A. Graves, A. I. Budavari, and B. M. Spiegelman, “mPPARγ2: tissue-specific regulator of an adipocyte enhancer,” Genes & Development, vol. 8, no. 10, pp. 1224–1234, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Fajas, D. Auboeuf, E. Raspé et al., “The organization, promoter analysis, and expression of the human PPARγ gene,” The Journal of Biological Chemistry, vol. 272, no. 30, pp. 18779–18789, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Tontonoz, E. Hu, and B. M. Spiegelman, “Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor,” Cell, vol. 79, no. 7, pp. 1147–1156, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. J. I. Park, “The role of 15d-PGJ2, a natural ligand for peroxisome proliferator-activated receptor γ (PPARγ), in cancer,” Cellular and Genetic Practices for Translational Medicine, pp. 169–195, 2011. View at Google Scholar
  8. J.-I. Park and J.-Y. Kwak, “The role of peroxisome proliferator-activated receptors in colorectal cancer,” PPAR Research, vol. 2012, Article ID 876418, 12 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Puigserver, Z. Wu, C. W. Park, R. Graves, M. Wright, and B. M. Spiegelman, “A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis,” Cell, vol. 92, no. 6, pp. 829–839, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Lin, P. T. Tarr, R. Yang et al., “PGC-1β in the regulation of hepatic glucose and energy metabolism,” The Journal of Biological Chemistry, vol. 278, no. 33, pp. 30843–30848, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Kressler, S. N. Schreiber, D. Knutti, and A. Kralli, “The PGC-1-related protein PERC is a selective coactivator of estrogen receptor α,” The Journal of Biological Chemistry, vol. 277, no. 16, pp. 13918–13925, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. U. Andersson and R. C. Scarpulla, “PGC-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells,” Molecular and Cellular Biology, vol. 21, no. 11, pp. 3738–3749, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Lin, P. Puigserver, J. Donovan, P. Tarr, and B. M. Spiegelman, “Peroxisome proliferator-activated receptor γ coactivator 1β (PGC-1β), a novel PGC-1-related transcription coactivator associated with host cell factor,” The Journal of Biological Chemistry, vol. 277, no. 3, pp. 1645–1648, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Monsalve, Z. Wu, G. Adelmant, P. Puigserver, M. Fan, and B. M. Spiegelman, “Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1,” Molecular Cell, vol. 6, no. 2, pp. 307–316, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. G. D. Girnun, “The diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancer,” Seminars in Cell & Developmental Biology, vol. 23, no. 4, pp. 381–388, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Yu and Y. Xin, “Down-regulated expressions of PPARγ and its coactivator PGC-1 are related to gastric carcinogenesis and Lauren’s classification in gastric carcinoma,” Chinese Journal of Cancer Research, vol. 25, no. 6, pp. 704–714, 2013. View at Google Scholar
  17. M. Shiota, A. Yokomizo, Y. Tada et al., “Peroxisome proliferator-activated receptor γ coactivator-1α interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR,” Molecular Endocrinology, vol. 24, no. 1, pp. 114–127, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. J. Mansure, R. Nassim, and W. Kassouf, “Peroxisome proliferator-activated receptor γ in bladder cancer: A promising therapeutic target,” Cancer Biology & Therapy, vol. 8, no. 7, pp. 6–15, 2009. View at Google Scholar · View at Scopus
  19. R. N. DuBois, R. Gupta, J. Brockman, B. S. Reddy, S. L. Krakow, and M. A. Lazar, “The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonic cancers,” Carcinogenesis, vol. 19, no. 1, pp. 49–53, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Sarraf, E. Mueller, D. Jones et al., “Differentiation and reversal of malignant changes in colon cancer through PPARγ,” Nature Medicine, vol. 4, no. 9, pp. 1046–1052, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Mueller, P. Sarraf, P. Tontonoz et al., “Terminal differentiation of human breast cancer through PPARγ,” Molecular Cell, vol. 1, no. 3, pp. 465–470, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Kubota, K. Koshizuka, E. A. Williamson et al., “Ligand for peroxisome proliferator-activated receptor gamma (Troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo,” Cancer Research, vol. 58, no. 15, pp. 3344–3352, 1998. View at Google Scholar · View at Scopus
  23. T. Wang, J. Xu, X. Yu, R. Yang, and Z. C. Han, “Peroxisome proliferator-activated receptor γ in malignant diseases,” Critical Reviews in Oncology/Hematology, vol. 58, no. 1, pp. 1–14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. J. O. Ban, D. H. Kwak, J. H. Oh et al., “Suppression of NF-κB and GSK-3β is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone,” Chemico-Biological Interactions, vol. 188, no. 1, pp. 75–85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. N. J. Lee, J. H. Oh, J. O. Ban et al., “4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: P21-mediated suppression of NF-kB activity,” British Journal of Pharmacology, vol. 168, no. 5, pp. 1133–1145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Hou, F. Moreau, and K. Chadee, “PPARγ is an E3 ligase that induces the degradation of NFκB/p65,” Nature Communications, vol. 3, article 1300, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Hou, J. Gao, H. Xu et al., “PPARγ E3 ubiquitin ligase regulates MUC1-C oncoprotein stability,” Oncogene, vol. 33, no. 49, pp. 5619–5625, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Sawayama, T. Ishimoto, M. Watanabe et al., “Small molecule agonists of PPAR-γ exert therapeutic effects in esophageal cancer,” Cancer Research, vol. 74, no. 2, pp. 575–585, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Papi, S. De Carolis, S. Bertoni et al., “PPARgamma and RXR ligands disrupt the inflammatory cross-talk in the hypoxic breast cancer stem cells niche,” Journal of Cellular Physiology, vol. 229, no. 11, pp. 1595–1606, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Prost, F. Relouzat, M. Spentchian et al., “Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists,” Nature, vol. 525, no. 7569, pp. 380–383, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Guo, X. Ren, Y. Dong et al., “Constitutive expression of PPARγ inhibits proliferation and migration of gastric cancer cells and down-regulates Wnt/β-catenin signaling pathway downstream target genes TERT and ENAH,” Gene, vol. 584, no. 1, pp. 31–37, 2016. View at Publisher · View at Google Scholar
  32. A. Pseftogas, C. Gonidas, and G. Mosialos, “Activation of peroxisome proliferator-activated receptor gamma in mammary epithelial cells upregulates the expression of tumor suppressor Cyld to mediate growth inhibition and anti-inflammatory effects,” The International Journal of Biochemistry & Cell Biology, vol. 82, pp. 49–56, 2017. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Rovito, G. Gionfriddo, I. Barone et al., “Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression,” Oncotarget, vol. 7, no. 40, pp. 65109–65124, 2016. View at Publisher · View at Google Scholar
  34. C. Lee, S. Wu, C. Hong et al., “Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancers,” The American Journal of Pathology, vol. 178, no. 5, pp. 2066–2076, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Bhalla, B. J. Hwang, R. E. Dewi et al., “PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis,” Cancer Research, vol. 71, no. 21, pp. 6888–6898, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. S.-W. Shin, S.-H. Yun, E.-S. Park, J.-S. Jeong, J.-Y. Kwak, and J.-I. Park, “Overexpression of PGC-1α enhances cell proliferation and tumorigenesis of HEK293 cells through the upregulation of Sp1 and Acyl-CoA binding protein,” International Journal of Oncology, vol. 46, no. 3, pp. 1328–1342, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Vazquez, J.-H. Lim, H. Chim et al., “PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress,” Cancer Cell, vol. 23, no. 3, pp. 287–301, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. S. McGuirk, S. Gravel, G. Deblois et al., “PGC-1α supports glutamine metabolism in breast cancer,” Cancer & Metabolism, vol. 5, no. 1, p. 22, 2013. View at Publisher · View at Google Scholar
  39. J. B. Tennakoon, Y. Shi, J. J. Han et al., “Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch,” Oncogene, vol. 33, no. 45, pp. 5251–5261, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Taguchi, O. Delgado, M. Çeliktaş et al., “Proteomic signatures associated with p53 mutational status in lung adenocarcinoma,” Proteomics, vol. 14, no. 23-24, pp. 2750–2759, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Zhang, Y. Ba, C. Liu et al., “PGC-1α induces apoptosis in human epithelial ovarian cancer cells through a PPARγ-dependent pathway,” Cell Research, vol. 17, no. 4, pp. 363–373, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. H. J. Lee, Y. Su, P. H. Yin, H. C. Lee, and C. W. Chi, “PPARγ/PGC-1α pathway in E-cadherin expression and motility of HepG2 cells,” Anticancer Research, vol. 29, no. 12, pp. 5057–5063, 2009. View at Google Scholar
  43. I. D'Errico, L. Salvatore, S. Murzilli et al., “Peroxisome proliferator-activated receptor-γ coactivator 1-α (PGC1α) is a metabolic regulator of intestinal epithelial cell fate,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 108, no. 16, pp. 6603–6608, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. X. Wang and C. T. Moraes, “Increases in mitochondrial biogenesis impair carcinogenesis at multiple levels,” Molecular Oncology, vol. 5, no. 5, pp. 399–409, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. V. Torrano, L. Valcarcel-Jimenez, A. R. Cortazar et al., “The metabolic co-regulator PGC1α suppresses prostate cancer metastasis,” Nature Cell Biology, vol. 18, no. 6, pp. 645–656, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Luo, J.-H. Lim, Y. Lee et al., “A PGC1α-mediated transcriptional axis suppresses melanoma metastasis,” Nature, vol. 537, no. 7620, pp. 422–426, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Ahmad, D. Raina, V. Trivedi et al., “MUC1 oncoprotein activates the IκB kinase β complex and constitutive NF-κB signalling,” Nature Cell Biology, vol. 9, no. 12, pp. 1419–1427, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Cascio, L. Zhang, and O. J. Finn, “MUC1 protein expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with nuclear factor-κB p65 and binding to cytokine promoters: Importance of extracellular domain,” The Journal of Biological Chemistry, vol. 286, no. 49, pp. 42248–42256, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Ahmad, D. Raina, M. D. Joshi et al., “MUC1-C oncoprotein functions as a direct activator of the nuclear factor-κB p65 transcription factor,” Cancer Research, vol. 69, no. 17, pp. 7013–7021, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Ahmad, H. Rajabi, M. Kosugi et al., “MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop,” Science Signaling, vol. 4, no. 160, article no. ra9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. X. Wei, H. Xu, and D. Kufe, “Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response,” Cancer Cell, vol. 7, no. 2, pp. 167–178, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Ahmad, M. Alam, H. Rajabi, and D. Kufe, “The MUC1-C oncoprotein binds to the BH3 domain of the pro-apoptotic BAX protein and blocks BAX function,” The Journal of Biological Chemistry, vol. 287, no. 25, pp. 20866–20875, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Apsel Winger and N. P. Shah, “PPARγ: Welcoming the New Kid on the CML Stem Cell Block,” Cancer Cell, vol. 28, no. 4, article no. 2152, pp. 409–411, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. J. M. Egan, “Targeting stem cells in chronic myeloid leukemia with a PPAR-γ agonist,” The New England Journal of Medicine, vol. 373, no. 20, pp. 1973–1975, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Wang, H. Tan, D. Xu et al., “The combinatory effects of PPAR-γ agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cells,” International Journal of Molecular Medicine, vol. 34, no. 1, pp. 262–268, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Clevers and R. Nusse, “Wnt/β-catenin signaling and disease,” Cell, vol. 149, no. 6, pp. 1192–1205, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. X. Song, N. Xin, W. Wang, and C. Zhao, “Wnt/β-catenin, an oncogenic pathway targeted by H. pylori in gastric carcinogenesis,” Oncotarget , vol. 6, no. 34, pp. 35579–35588, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. A. V. Kwiatkowski, F. B. Gertler, and J. J. Loureiro, “Function and regulation of Ena/VASP proteins,” Trends in Cell Biology, vol. 13, no. 7, pp. 386–392, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Hoffmeyer, A. Raggioli, S. Rudloff et al., “Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells,” Science, vol. 336, no. 6088, pp. 1549–1554, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Najafov, T. Şeker, I. Even et al., “MENA is a transcriptional target of the Wnt/beta-catenin pathway,” PLoS ONE, vol. 7, no. 5, Article ID e37013, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. K. T. Pate, C. Stringari, S. Sprowl-Tanio et al., “Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer,” EMBO Journal, vol. 33, no. 13, pp. 1454–1473, 2014. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. Lecarpentier, V. Claes, A. Vallée, and J. Hébert, “Interactions between PPAR Gamma and the Canonical Wnt/Beta-Catenin Pathway in Type 2 Diabetes and Colon Cancer,” PPAR Research, vol. 2017, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  63. G. R. Bignell, W. Warren, S. Seal et al., “Identification of the familial cylindromatosis tumor-suppressor gene,” Nature Genetics, vol. 25, no. 2, pp. 160–165, 2000. View at Google Scholar
  64. D. Komander, F. Reyes-Turcu, J. D. F. Licchesi, P. Odenwaelder, K. D. Wilkinson, and D. Barford, “Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains,” EMBO Reports, vol. 10, no. 5, pp. 466–473, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. N. Rajan and A. Ashworth, “Inherited cylindromas: Lessons from a rare tumour,” The Lancet Oncology, vol. 16, no. 9, article no. 213, pp. e460–e469, 2015. View at Publisher · View at Google Scholar · View at Scopus
  66. A. Müller, B. Homey, H. Soto et al., “Involvement of chemokine receptors in breast cancer metastasis,” Nature, vol. 410, no. 6824, pp. 50–56, 2001. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Hassan, C. Ferrario, U. Saragovi et al., “The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancer,” The American Journal of Pathology, vol. 175, no. 1, pp. 66–73, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. J.-J. Lee, A. Drakaki, D. Iliopoulos, and K. Struhl, “MiR-27b targets PPARγ to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells,” Oncogene, vol. 31, no. 33, pp. 3818–3825, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. K. L. Schaefer, K. Wada, H. Takahashi et al., “Peroxisome proliferator-activated receptor γ inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells,” Cancer Research, vol. 65, no. 6, pp. 2251–2259, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Y. Zaytseva, X. Wang, R. C. Southard, N. K. Wallis, and M. W. Kilgore, “Down-regulation of PPARgamma1 suppresses cell growth and induces apoptosis in MCF-7 breast cancer cells,” Molecular Cancer, vol. 7, article no. 90, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. X. Wang, Y. Sun, J. Wong, and D. S. Conklin, “PPARγ maintains ERBB2-positive breast cancer stem cells,” Oncogene, vol. 32, no. 49, pp. 5512–5521, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. D. Kesanakurti, D. Maddirela, Y. K. Banasavadi-Siddegowda et al., “A novel interaction of PAK4 with PPARγ to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma,” Oncogene, vol. 36, no. 37, pp. 5309–5320, 2017. View at Google Scholar
  73. F. S. Forootan, S. S. Forootan, X. Gou et al., “Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter,” Oncotarget, vol. 7, no. 8, pp. 9322–9339, 2016. View at Publisher · View at Google Scholar · View at Scopus
  74. C. Patitucci, G. Couchy, A. Bagattin et al., “Hepatocyte nuclear factor 1α suppresses steatosis-associated liver cancer by inhibiting PPARγ transcription,” The Journal of Clinical Investigation, vol. 127, no. 5, pp. 1873–1888, 2017. View at Publisher · View at Google Scholar
  75. A. Kourtidis, R. Srinivasaiah, R. D. Carkner, M. J. Brosnan, and D. S. Conklin, “Peroxisome proliferator-activated receptor-γ protects ERBB2-positive breast cancer cells from palmitate toxicity,” Breast Cancer Research, vol. 11, no. 2, article R16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. T. Lapidot, C. Sirard, J. Vormoor et al., “A cell initiating human acute myeloid leukaemia after transplantation into SCID mice,” Nature, vol. 367, no. 6464, pp. 645–648, 1994. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, and M. F. Clarke, “Prospective identification of tumorigenic breast cancer cells,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 100, no. 7, pp. 3983–3988, 2003. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Smalley and A. Ashworth, “Stem cells and breast cancer: a field in transit,” Nature Reviews Cancer, vol. 3, no. 11, pp. 832–844, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. B. D. Craene and G. Berx, “Regulatory networks defining EMT during cancer initiation and progression,” Nature Reviews Cancer, vol. 13, no. 2, pp. 97–110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. H. Zheng, M. Shen, Y.-L. Zha et al., “PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis,” Cancer Cell, vol. 26, no. 3, pp. 358–373, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. S. Lamouille, J. Xu, and R. Derynck, “Molecular mechanisms of epithelial-mesenchymal transition,” Nature Reviews Molecular Cell Biology, vol. 15, no. 3, pp. 178–196, 2014. View at Publisher · View at Google Scholar
  82. F. A. Siebzehnrubl, D. J. Silver, B. Tugertimur et al., “The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance,” EMBO Molecular Medicine, vol. 5, no. 8, pp. 1196–1212, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. B. Dummler, K. Ohshiro, R. Kumar, and J. Field, “Pak protein kinases and their role in cancer,” Cancer Metastasis Reviews, vol. 28, no. 1-2, pp. 51–63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. M. Radu, G. Semenova, R. Kosoff, and J. Chernoff, “PAK signalling during the development and progression of cancer,” Nature Reviews Cancer, vol. 14, no. 1, pp. 13–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  85. D. Kesanakurti, C. Chetty, D. Rajasekhar Maddirela, M. Gujrati, and J. S. Rao, “Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma,” Cell Death & Disease, vol. 3, article e445, 2012. View at Google Scholar · View at Scopus
  86. M. K. Y. Siu, H. Y. Chan, D. S. H. Kong et al., “p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 107, no. 43, pp. 18622–18627, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. A. D. Whale, A. Dart, M. Holt, G. E. Jones, and C. M. Wells, “PAK4 kinase activity and somatic mutation promote carcinoma cell motility and influence inhibitor sensitivity,” Oncogene, vol. 32, no. 16, pp. 2114–2120, 2013. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Feilchenfeldt, M.-A. Bründler, C. Soravia, M. Tötsch, and C. A. Meier, “Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer: Reduced expression of PPARγ-coactivator 1 (PGC-1),” Cancer Letters, vol. 203, no. 1, pp. 25–33, 2014. View at Publisher · View at Google Scholar · View at Scopus
  89. G. Watkins, A. Douglas-Jones, R. Mansel, and W. Jiang, “The localisation and reduction of nuclear staining of PPARγ and PGC-1 in human breast cancer,” Oncology Reports, vol. 12, no. 2, pp. 483–488, 2004. View at Google Scholar
  90. S. Srivastava, J. N. Barrett, and C. T. Moraes, “PGC-1α/β upregulation is associated with improved oxidative phosphorylation in cells harboring nonsense mtDNA mutations,” Human Molecular Genetics, vol. 16, no. 8, pp. 993–1005, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. R. Haq, J. Shoag, P. Andreu-Perez et al., “Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF,” Cancer Cell, vol. 23, no. 3, pp. 302–315, 2013. View at Publisher · View at Google Scholar · View at Scopus
  92. K. W. Fisher, B. Das, R. L. Kortum, O. V. Chaika, and R. E. Lewis, “Kinase suppressor of ras 1 (KSR1) regulates PGC1α and estrogen-related receptor α to promote oncogenic ras-dependent anchorage-independent growth,” Molecular and Cellular Biology, vol. 31, no. 12, pp. 2453–2461, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. V. S. LeBleu, J. T. O’Connell, K. N. G. Herrera et al., “PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis,” Nature Cell Biology, vol. 16, no. 10, pp. 992–1003, 2014. View at Publisher · View at Google Scholar
  94. R. J. DeBerardinis, N. Sayed, D. Ditsworth, and C. B. Thompson, “Brick by brick: metabolism and tumor cell growth,” Current Opinion in Genetics & Development, vol. 18, no. 1, pp. 54–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. C. T. Hensley, A. T. Wasti, and R. J. DeBerardinis, “Glutamine and cancer: cell biology, physiology, and clinical opportunities,” The Journal of Clinical Investigation, vol. 123, no. 9, pp. 3678–3684, 2013. View at Publisher · View at Google Scholar · View at Scopus
  96. N. Sen, Y. K. Satija, and S. Das, “PGC-1α, a key modulator of p53, promotes cell survival upon metabolic stress,” Molecular Cell, vol. 44, no. 4, pp. 621–634, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. W. Chen, Q. Wang, L. Bai et al., “RIP1 maintains DNA integrity and cell proliferation by regulating PGC-1α-mediated mitochondrial oxidative phosphorylation and glycolysis,” Cell Death & Differentiation, vol. 21, no. 7, pp. 1061–1070, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. Z. Arany, S.-Y. Foo, Y. Ma et al., “HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α,” Nature, vol. 451, no. 7181, pp. 1008–1012, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. K. A. O'Hagan, S. Cocchiglia, A. V. Zhdanov et al., “PGC-1α is coupled to HIF-1α-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 106, no. 7, pp. 2188–2193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. K. A. Rasbach, R. K. Gupta, J. L. Ruas et al., “PGC-1α regulates a HIF2α-dependent switch in skeletal muscle fiber types,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 107, no. 50, pp. 21866–21871, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. H. Zhang, P. Gao, R. Fukuda et al., “HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity,” Cancer Cell, vol. 11, no. 5, pp. 407–420, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. E. LaGory, C. Wu, C. Taniguchi et al., “Suppression of PGC-1α is critical for reprogramming oxidative metabolism in renal cell carcinoma,” Cell Reports, vol. 12, no. 1, pp. 116–127, 2015. View at Publisher · View at Google Scholar
  103. H. Simonnet, N. Alazard, K. Pfeiffer et al., “Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma,” Carcinogenesis, vol. 23, no. 5, pp. 759–768, 2002. View at Publisher · View at Google Scholar · View at Scopus
  104. N. Minsky and R. G. Roeder, “Direct link between metabolic regulation and the heat-shock response through the transcriptional regulator PGC-1α,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 112, no. 42, pp. E5669–E5678, 2015. View at Publisher · View at Google Scholar · View at Scopus
  105. S. Zhang, X. Liu, J. Liu, H. Guo, H. Xu, and G. Zhang, “PGC-1α interacts with microRNA-217 to functionally regulate breast cancer cell proliferation,” Biomedicne & Pharmacotherapy, pp. 541–548, 2017. View at Google Scholar
  106. E. Piskounova, M. Agathocleous, M. M. Murphy et al., “Oxidative stress inhibits distant metastasis by human melanoma cells,” Nature, vol. 527, no. 7577, pp. 186–191, 2015. View at Publisher · View at Google Scholar
  107. C. Luo, H. R. Widlund, and P. Puigserver, “PGC-1 Coactivators: Shepherding the Mitochondrial Biogenesis of Tumors,” Trends in Cancer, vol. 2, no. 10, pp. 619–631, 2016. View at Publisher · View at Google Scholar · View at Scopus